Invention Grant
US07935718B2 Treatment of dyskinesia 失效
运动障碍的治疗

Treatment of dyskinesia
Abstract:
The present invention relates to the use of compounds that enhance H3-histamine receptor activity, or activation (e.g. H3-histamine receptor agonists) for the treatment of dyskinesia. The compounds are particularly useful for treating dyskinesia associated with parkinsonian therapy.
Public/Granted literature
Information query
Patent Agency Ranking
0/0